Reduction of Eyedrop Volume for Topical Ophthalmic Medications with the Nanodropper Bottle Adaptor

References

• Newman-Casey PA, Robin AL, Blachley T, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122(7):1308–1316. doi:10.1016/j.ophtha.2015.03.026
   PubMed Web of Science ®Google Scholar
• Mishima S, Gasset A, Klyce SD, Baum JL. Determination of tear volume and tear flow. Invest Ophthalmol Vis Sci. 1966;5(3):264–276.
   Google Scholar
• Robin AL, Covert D. Beyond compliance: getting the drops. Rev Ophthalmol. 2005;112(5):863–868. doi:10.1016/j.ophtha.2004.12.026
   Google Scholar
• Van Santvliet L, Ludwig A. Determinants of eye drop size. Surv Ophthalmol. 2004;49(2):197–213. doi:10.1016/j.survophthal.2003.12.009
   PubMed Web of Science ®Google Scholar
• Nagataki S, Mishima S. Pharmacokinetics of instilled drugs in the human eye. Int Ophthalmol Clin. 1980;20(3):33–49. doi:10.1097/00004397-198002030-00006
   PubMedGoogle Scholar
• File R, Patton T. Topically applied pilocarpine. Human pupillary response as a function of drop size. Arch Ophthalmol. 1980;98(1):112–115. doi:10.1001/archopht.1980.01020030114010
   PubMedGoogle Scholar
• Agrahari V, Mandal A, Agrahari V, et al. A comprehensive insight on ocular pharmacokinetics. Drug Deliv Transl Res. 2016;6(6):735–754. doi:10.1007/s13346-016-0339-2
   PubMed Web of Science ®Google Scholar
• Farkouh A, Frigo P, Czejka M. Systemic side effects of eye drops: a pharmacokinetic perspective. Clin Ophthalmol. 2016;10:2433–2441. doi:10.2147/OPTH.S118409
   PubMed Web of Science ®Google Scholar
• Moore DB, Beck J, Kryscio RJ. An objective assessment of the variability in number of drops per bottle of glaucoma medication. BMC Ophthalmol. 2017;17(1). doi:10.1186/s12886-017-0473-8
   PubMedGoogle Scholar
• Newman-Casey PA, Salman M, Lee PP, Gatwood JD. Cost-utility analysis of glaucoma medication adherence. In: Ophthalmology. Vol. 127. Elsevier Inc.;2020:589–598. doi:10.1016/j.ophtha.2019.09.041
   Google Scholar
• Olthoff C, Schouten J, van de Borne B, Webers C. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology. 2005;112(6):953–961. doi:10.1016/j.ophtha.2004.12.035
   PubMed Web of Science ®Google Scholar
• Schwartz G, Quigley H. Adherence and persistence with glaucoma therapy. Surv Ophthalmol. 2008;58:S57–68. doi:10.1016/j.survophthal.2008.08.002
   Google Scholar
• Kahook MY. Developments in dosing aids and adherence devices for glaucoma therapy: current and future perspectives. Expert Rev Med Devices. 2007;4(2):261–266. doi:10.1586/17434440.4.2.261
   PubMed Web of Science ®Google Scholar
• Moore DB, Walton C, Moeller KL, Slabaugh MA, Mudumbai RC, Chen PP. Prevalence of self-reported early glaucoma eye drop bottle exhaustion and associated risk factors: a patient survey. BMC Ophthalmol. 2014;14(1). doi:10.1186/1471-2415-14-79
   PubMedGoogle Scholar
• Early eyedrop prescription refills. Academy-backed Eyedrop Refill Bill becomes law in Pennsylvania. American Academy of Ophthalmology. Available from: https://www.aao.org/advocacy/eyedrop-refills Accessed March 12, 2023.
   Google Scholar
• Hoppe CB, Yonamine S, Kao BW, et al. Randomized Trial to evaluate the efficacy of the nanodropper device for pupillary dilation and cycloplegia in children. Ophthalmology. 2022;130(3):324–330. doi:10.1016/j.ophtha.2022.10.016
   PubMed Web of Science ®Google Scholar
• Xu C, Guo R, Huang D, Ji J, Liu W. Daily costs and cost effectiveness of glaucoma fixed combinations in China. J Ophthalmol. 2020;2020:1–5. doi:10.1155/2020/2406783
   Web of Science ®Google Scholar
• Queen JH, Feldman RM, Lee DA. Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma. Am J Ophthalmol. 2016;163:70–74.e1. doi:10.1016/j.ajo.2015.11.021
   PubMed Web of Science ®Google Scholar
• Kumar S, Karki R, Meena M, Prakash T, Rajeswari T, Goli D. Reduction in drop size of ophthalmic topical drop preparations and the impact of treatment. J Adv Pharm Technol Res. 2011;2(3):192–194. doi:10.4103/2231-4040.85540
   PubMedGoogle Scholar
• Al-Jumaian N, Malik R, Khandekar R, et al. Bottle characteristics of topical international glaucoma medications versus local brands in Saudi Arabia. Middle East Afr J Ophthalmol. 2016;23(4):296–301. doi:10.4103/0974-9233.194077
   PubMedGoogle Scholar
• Whitson JT, Love R, Brown RH, Lynch MG, Schoenwald RD. The effect of reduced eyedrop size and eyelid closure on the therapeutic index of phenylephrine. Am J Ophthalmol. 1993;115(3):357–359. doi:10.1016/S0002-9394(14)73588-3
   PubMed Web of Science ®Google Scholar
• Lynch MG, Brown RH, Goode SM, Schoenwald RD, Chien DS. Reduction of phenylephrine drop size in infants achieves equal dilation with decreased systemic absorption. Arch Ophthalmol. 1987;105(10):1364–1365. doi:10.1001/archopht.1987.01060100066027
   PubMedGoogle Scholar
• Baudouin C. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma. Acta Ophthalmol. 2008;86(7):716–726. doi:10.1111/j.1755-3768.2008.01250.x
   PubMed Web of Science ®Google Scholar
• Zhang X, Vadoothker S, Munir WM, Saeedi O. Ocular surface disease and glaucoma medications: a clinical approach. Eye Contact Lens. 2019;45(1):11–18. doi:10.1097/ICL.0000000000000544
   PubMed Web of Science ®Google Scholar
• Kahook MY, Noecker RJ. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with SofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears. Cornea. 2008;27(3):339–343. doi:10.1097/ICO.0b013e31815cf651
   PubMed Web of Science ®Google Scholar
• Kahook MY, Noecker R. Quantitative analysis of conjunctival goblet cells after chronic application of topical drops. Adv Ther. 2008;25(8):743–751. doi:10.1007/s12325-008-0078-y
   PubMed Web of Science ®Google Scholar
• Rasmussen CA, Kaufman PL, Kiland JA. Benzalkonium chloride and glaucoma. J Ocular Pharmacol Therap. 2014;30(2–3):163–169. doi:10.1089/jop.2013.0174
   PubMed Web of Science ®Google Scholar
• Ammar DA, Kahook MY. Effects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell lines. Br J Ophthalmol. 2011;95(10):1466–1469. doi:10.1136/bjophthalmol-2011-300012
   PubMed Web of Science ®Google Scholar
• Gray RH. The influence of drop size on pupil dilatation. Eye. 1991;5(5):615–619. doi:10.1038/eye.1991.107
   PubMedGoogle Scholar
• Lal A, Kataria V, Rajpal A, Khanna N. Pharmacodynamic effects of pilocarpine eye drop enhanced by decreasing its volume of instillation. Indian J Physiol Pharmacol. 1995;39(3):267–270.
   PubMedGoogle Scholar
• Craig EW, Griffiths PG. Effect on mydriasis of modifying the volume of phenylephrine drops. Br J Ophthalmol. 1991;75(4):222–223. doi:10.1136/bjo.75.4.222
   PubMed Web of Science ®Google Scholar
• Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg. 1995;26(3):233–236.
   PubMedGoogle Scholar
• Sleath B, Robin AL, Covert D, Byrd JE, Tudor G, Svarstad B. Patient-reported behavior and problems in using glaucoma medications. Ophthalmology. 2006;113(3):431–436. doi:10.1016/j.ophtha.2005.10.034
   PubMed Web of Science ®Google Scholar
• Schmier JK, Halpern MT, Jones ML. The economic implications of glaucoma: a literature review. Pharmacoeconomics. 2007;25(4):287–308. doi:10.2165/00019053-200725040-00003
   PubMed Web of Science ®Google Scholar
• Na KH, Yoo C, Park JH, Kim YY. Eye drop dispenser type and medication possession ratio in patients with glaucoma: single-use containers versus multiple-use bottles. Am J Ophthalmol. 2018;188:9–18. doi:10.1016/j.ajo.2018.01.011
   PubMed Web of Science ®Google Scholar
• Tamrat L, Gelaw Y, Beyene G, Gize A. Microbial contamination and antimicrobial resistance in use of ophthalmic solutions at the department of ophthalmology, Jimma University Specialized Hospital, Southwest Ethiopia. Can J Infect Dis Med Microbiol. 2019;2019:5372530. doi:10.1155/2019/5372530
   PubMed Web of Science ®Google Scholar
• Palmer DJ, Robin AL, McCabe CM, Chang DF. Reducing topical drug waste in ophthalmic surgery multisociety position paper. J Cataract Refract Surg. 2022;4(8):1073–1077. doi:10.1097/j.jcrs.0000000000000975
   Google Scholar
• Chaudhary OR. How long can you use prescription eye drops after opening them? Am Acad Ophthalmol. 2022. Available from: https://www.aao.org/eye-health/ask-ophthalmologist-q/how-long-after-opening-is-it-safe-to-use-eye-drops
   Google Scholar